It has been reported that rapid acetylators genotypes of NAT2 may be at increased risk of liver and colon cancer [9], hepatocellular carcinoma [10] and colorectal cancer [11] when exposed to environmental arylamines carcinogens, due to NAT2 rapid acetylator mediated O-acetylation. The gene discussed is NAT2; the disease is colonic neoplasm.